JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 39.50
-0.02 (-0.05%)
Aug 14, 2026, 4:08 PM HKT
JD Health International Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 79,039 | 73,441 | 58,160 | 53,530 | 46,736 | 30,682 | |
Revenue Growth | 21.40% | 26.27% | 8.65% | 14.54% | 52.32% | 58.30% |
Cost of Revenue | 59,046 | 55,242 | 44,851 | 41,665 | 36,845 | 23,485 |
Gross Profit | 19,993 | 18,199 | 13,309 | 11,865 | 9,892 | 7,197 |
Selling, General & Admin | 13,260 | 12,624 | 10,499 | 9,938 | 8,871 | 7,670 |
Research & Development | 1,807 | 1,634 | 1,330 | 1,226 | 1,067 | 892.91 |
Operating Expenses | 15,144 | 14,401 | 12,146 | 11,234 | 10,037 | 8,601 |
Operating Income | 4,850 | 3,798 | 1,163 | 630.85 | -145.12 | -1,404 |
Interest Expense | -15.67 | -11.1 | -8.19 | -9.49 | -9.1 | -6 |
Interest & Investment Income | 1,365 | 1,538 | 1,961 | 1,949 | 864.27 | 457.57 |
Earnings From Equity Investments | -58.71 | -64.05 | -85.53 | -70.76 | -96.76 | -94.17 |
Other Non Operating Income (Expenses) | 1,277 | 769.61 | 1,767 | 193.71 | 82.52 | 145.15 |
EBT Excluding Unusual Items | 7,417 | 6,030 | 4,797 | 2,693 | 695.81 | -901.49 |
Pretax Income | 7,417 | 6,030 | 4,797 | 2,693 | 695.81 | -901.49 |
Income Tax Expense | 1,206 | 662.89 | 639.66 | 550.47 | 312.58 | 171.33 |
Earnings From Continuing Operations | 6,211 | 5,367 | 4,157 | 2,143 | 383.23 | -1,073 |
Minority Interest in Earnings | 4.59 | 8.3 | 4.83 | -1.04 | -3.12 | -0.69 |
Net Income | 6,216 | 5,375 | 4,162 | 2,142 | 380.11 | -1,074 |
Net Income to Common | 6,216 | 5,375 | 4,162 | 2,142 | 380.11 | -1,074 |
Net Income Growth | 31.66% | 29.16% | 94.31% | 463.49% | - | - |
Shares Outstanding (Basic) | 3,172 | 3,163 | 3,143 | 3,124 | 3,107 | 3,095 |
Shares Outstanding (Diluted) | 3,204 | 3,196 | 3,160 | 3,164 | 3,144 | 3,095 |
Shares Change | 0.83% | 1.14% | -0.12% | 0.62% | 1.60% | 40.13% |
EPS (Basic) | 1.96 | 1.70 | 1.32 | 0.69 | 0.12 | -0.35 |
EPS (Diluted) | 1.94 | 1.68 | 1.32 | 0.68 | 0.12 | -0.35 |
EPS Growth | 31.03% | 27.27% | 94.12% | 466.67% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 8,239 | 10,023 | 4,286 | 4,544 | 5,865 | 2,929 |
Free Cash Flow Per Share | 2.57 | 3.14 | 1.36 | 1.44 | 1.86 | 0.95 |
Gross Margin | 25.30% | 24.78% | 22.88% | 22.17% | 21.16% | 23.46% |
Operating Margin | 6.14% | 5.17% | 2.00% | 1.18% | -0.31% | -4.58% |
Profit Margin | 7.86% | 7.32% | 7.16% | 4.00% | 0.81% | -3.50% |
Free Cash Flow Margin | 10.42% | 13.65% | 7.37% | 8.49% | 12.55% | 9.54% |
EBITDA | 5,091 | 3,975 | 1,315 | 794.92 | -60.93 | -1,372 |
EBITDA Margin | 6.44% | 5.41% | 2.26% | 1.49% | -0.13% | -4.47% |
D&A For EBITDA | 240.87 | 177.31 | 151.95 | 164.07 | 84.19 | 32.41 |
EBIT | 4,850 | 3,798 | 1,163 | 630.85 | -145.12 | -1,404 |
EBIT Margin | 6.14% | 5.17% | 2.00% | 1.18% | -0.31% | -4.58% |
Effective Tax Rate | 16.26% | 10.99% | 13.34% | 20.44% | 44.92% | - |
Advertising Expenses | - | 1,934 | 1,564 | 1,305 | 922.22 | 1,290 |